1.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospect...
by Haude, Michael, Prof
The Lancet (British edition), 2016, Vol.387 (10013), p.31-39
2.
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-...
by Haude, Michael, Prof
The Lancet (British edition), 2013, Vol.381 (9869), p.836-844
3.
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a ra...
by Kandzari, David E
The Lancet (British edition), 2017, Vol.390 (10105), p.1843-1852
4.
Overview of the Food and Drug Administration Circulatory System Devices Panel Meetings on WATCHMAN Left Atrial Appendage Closure Therapy
by Waksman, Ron, MD
The American journal of cardiology, 2015, Vol.115 (3), p.378-384
5.
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
by Erbel, Raimund, Prof
The Lancet (British edition), 2007, Vol.369 (9576), p.1869-1875
6.
Embedding a randomized clinical trial into an ongoing registry infrastructure: Unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutan...
by Hess, Connie N., MD, MHS
The American heart journal, 2013, Vol.166 (3), p.421-428.e1
7.
Feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis: Rationale and design of the Low Risk TAVR (LRT) study
by Rogers, Toby
The American heart journal, 2017, Vol.189, p.103-109
8.
Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement
by Barbash, Israel M., MD
The American heart journal, 2012, Vol.163 (6), p.1031-1036
9.
Overview of the 2016 US Food and Drug Administration Circulatory System Devices Panel Meeting on the Amplatzer Patent Foramen Ovale Occluder
by Rogers, Toby, MD
The American journal of cardiology, 2016, Vol.119 (1), p.153-155
10.
ACUITY-PCI: one drug does not fit all
by Waksman, Ron
The Lancet (British edition), 2007, Vol.369 (9565), p.881-882
11.
The Lipid-Rich Plaque Study of Vulnerable Plaques and Vulnerable Patients: Study Design and Rationale
by Waksman, Ron
The American heart journal, 2017, Vol.192, p.98-104
12.
Drug-eluting stents: is new necessarily better?
by Waksman, Ron
The Lancet (British edition), 2008, Vol.372 (9644), p.1126-1128
13.
Delayed consent: will there be a shift in approach for US primary percutaneous coronary intervention trials?
by MacKay, Charles R, PhD
The Lancet (British edition), 2015, Vol.386 (9994), p.714-716
14.
Prevalence and Impact of Pulmonary Hypertension on Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement
by Barbash, Israel M., MD
The American journal of cardiology, 2015, Vol.115 (10), p.1435-1442
15.
Choice of Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Impacts Hemodynamics Differently According to Aortic Annular Size
by Rogers, Toby, BM, BCh, PhD
The American journal of cardiology, 2016, Vol.119 (6), p.900-904
16.
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
by McFadden, Eugène P
The Lancet (British edition), 2004, Vol.364 (9444), p.1519-1521
17.
Overview of the 2017 US Food and Drug Administration Circulatory System Devices Panel meeting on the Sentinel Cerebral Protection System
by Rogers, Toby
The American heart journal, 2017, Vol.192, p.113-119
18.
Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee Meeting Regarding Cangrelor
by Lhermusier, Thibault, MD, PhD
The American journal of cardiology, 2015, Vol.115 (8), p.1154-1161
19.
Impact of Right Ventricular Function on Outcome of Severe Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement
by Koifman, Edward, MD
The American heart journal, 2016, Vol.184, p.141-147
20.
Polymer drug-eluting stents: is the future biodegradable?
by Waksman, Ron
The Lancet (British edition), 2011, Vol.378 (9807), p.1900-1902
